These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 19659653)
1. Serum hydrogen sulfide as a novel marker predicting bacterial involvement in patients with community-acquired lower respiratory tract infections. Chen YH; Yao WZ; Gao JZ; Geng B; Wang PP; Tang CS Respirology; 2009 Jul; 14(5):746-52. PubMed ID: 19659653 [TBL] [Abstract][Full Text] [Related]
2. [Endogenous hydrogen sulfide in patients with chronic obstructive pulmonary disease]. Chen YH; Yao WZ; Geng B; Ding YL; Lu M; Zhao MW; Tang CS Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):694-7. PubMed ID: 16255955 [TBL] [Abstract][Full Text] [Related]
4. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia. Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857 [TBL] [Abstract][Full Text] [Related]
5. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection. Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388 [TBL] [Abstract][Full Text] [Related]
6. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Chalmers JD; Singanayagam A; Hill AT Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306 [TBL] [Abstract][Full Text] [Related]
7. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic. File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762 [TBL] [Abstract][Full Text] [Related]
8. [Changes of the new gaseous transmitter H2S in patients with coronary heart disease]. Jiang HL; Wu HC; Li ZL; Geng B; Tang CS Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):951-4. PubMed ID: 16109547 [TBL] [Abstract][Full Text] [Related]
9. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Müller B; Morgenthaler N; Stolz D; Schuetz P; Müller C; Bingisser R; Bergmann A; Tamm M; Christ-Crain M Eur J Clin Invest; 2007 Feb; 37(2):145-52. PubMed ID: 17217381 [TBL] [Abstract][Full Text] [Related]
10. [Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof]. Liu XQ; Liu XQ; Jiang P; Huang H; Yan Y Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2246-9. PubMed ID: 19087670 [TBL] [Abstract][Full Text] [Related]
11. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Lisboa T; Seligman R; Diaz E; Rodriguez A; Teixeira PJ; Rello J Crit Care Med; 2008 Jan; 36(1):166-71. PubMed ID: 18007271 [TBL] [Abstract][Full Text] [Related]
12. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD. Tkacova R; Kluchova Z; Joppa P; Petrasova D; Molcanyiova A Respir Med; 2007 Aug; 101(8):1670-6. PubMed ID: 17449234 [TBL] [Abstract][Full Text] [Related]
13. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial. Schouten JA; Hulscher ME; Trap-Liefers J; Akkermans RP; Kullberg BJ; Grol RP; van der Meer JW Clin Infect Dis; 2007 Apr; 44(7):931-41. PubMed ID: 17342644 [TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia. Wu CL; Lee YL; Chang KM; Chang GC; King SL; Chiang CD; Niederman MS Crit Care Med; 2003 Mar; 31(3):812-7. PubMed ID: 12626989 [TBL] [Abstract][Full Text] [Related]
15. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Karadag F; Kirdar S; Karul AB; Ceylan E Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305 [TBL] [Abstract][Full Text] [Related]
16. Serum magnesium levels and acute exacerbation of chronic obstructive pulmonary disease: a retrospective study. Aziz HS; Blamoun AI; Shubair MK; Ismail MM; DeBari VA; Khan MA Ann Clin Lab Sci; 2005; 35(4):423-7. PubMed ID: 16254259 [TBL] [Abstract][Full Text] [Related]
17. [Effects of hydrogen sulfide on vascular inflammation in pulmonary hypertension induced by high pulmonary blood flow: experiment with rats]. Jin HF; Liang C; Liang JM; Tang CS; DU JB Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2235-9. PubMed ID: 19087668 [TBL] [Abstract][Full Text] [Related]
18. Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia. Igonin AA; Armstrong VW; Shipkova M; Lazareva NB; Kukes VG; Oellerich M Clin Biochem; 2004 Mar; 37(3):204-9. PubMed ID: 14972642 [TBL] [Abstract][Full Text] [Related]
19. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Bafadhel M; Clark TW; Reid C; Medina MJ; Batham S; Barer MR; Nicholson KG; Brightling CE Chest; 2011 Jun; 139(6):1410-1418. PubMed ID: 21030489 [TBL] [Abstract][Full Text] [Related]
20. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]